Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis - Takeaways - MDSpire

Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis

  • By

  • Konstantinos Pamporis

  • Paschalis Karakasis

  • Marios Sagris

  • Panagiotis Theofilis

  • Nikias Milaras

  • Antonia Pantelidaki

  • Iordanis Mourouzis

  • Nikolaos Fragakis

  • Konstantinos Vlachos

  • Athanasios Kordalis

  • Dimitrios Tsiachris

  • March 7, 2025

  • 0 min

Share

  • 1

    Asymptomatic atrial fibrillation (AF) prevalence is approximately 27%, indicating a significant portion of AF patients do not exhibit symptoms.

  • 2

    Risk factors positively associated with asymptomatic AF include male sex, diabetes mellitus, chronic kidney disease, and history of stroke/transient ischemic attack.

  • 3

    Heart failure is negatively associated with asymptomatic AF, suggesting that symptomatic patients may have different underlying conditions.

  • 4

    The variability in asymptomatic AF prevalence is influenced by the distribution of associated risk factors within different populations.

  • 5

    Findings from this meta-analysis could enhance AF screening practices, particularly targeting asymptomatic individuals for better management.

Original Source(s)

Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis

  • by Konstantinos Pamporis, Paschalis Karakasis, Marios Sagris, Panagiotis Theofilis, Nikias Milaras, Antonia Pantelidaki, Iordanis Mourouzis, Nikolaos Fragakis, Konstantinos Vlachos, Athanasios Kordalis, Dimitrios Tsiachris

  • March 7, 2025

Related Content

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention

Independent prognostic value of the triglyceride–glucose index and its incremental predictive contribution beyond traditional risk markers in acute heart failure: a retrospective cohort study

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial